Gil D. Rabinovici
Physiology · 2007–2021
A researcher in the Science corpus: 13 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 171 citations into it
- Psychiatry and Mental health — 160 citations into it
- Cognitive Neuroscience — 80 citations into it
- Molecular Biology — 32 citations into it
- Pharmacology — 13 citations into it
Whom Gil D. Rabinovici trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Gil D. Rabinovici's perspective
Ordered by how strongly the researchers Gil D. Rabinovici trusts endorse each paper. Same corpus, a different order for every researcher.
- Neuropathological stageing of Alzheimer-related changes
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
- Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain (NeuroImage)
- Potential antecedent marker of Alzheimer disease
- PET imaging of amyloid deposition in patients with mild cognitive impairment. (Neurobiology of Aging)
- The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive…
- A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual… (NeuroImage)
- Mild cognitive impairment represents early-stage Alzheimer disease. (Archives of Neurology)
- Neuropathologic features of amnestic mild cognitive impairment. (Archives of Neurology)
- An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest (NeuroImage)
Their papers
- Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins (2007) — 1,096 citations
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) — 636 citations
- Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group (2021) — 763 citations
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration (2020) — 613 citations
- Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease (2017) — 688 citations
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease (2017) — 420 citations
- PET Imaging of Tau Deposition in the Aging Human Brain (2016) — 1,102 citations
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. (2016) — 1,084 citations
- Prevalence of Amyloid PET Positivity in Dementia Syndromes (2015) — 625 citations
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. (2014) — 3,079 citations
- Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease (2013) — 676 citations
- Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. (2010) — 988 citations
- Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. (2009) — 695 citations